Publications
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | Second Faculty of Medicine, First Faculty of Medicine
- The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- The Immune Contexture of Liposarcoma and Its Clinical Implications2022 | Second Faculty of Medicine, First Faculty of Medicine
- The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials2021 | Second Faculty of Medicine, First Faculty of Medicine
- Novel insights into the immunotherapy of soft tissue sarcomas: Do we need a change of perspective?2021 | Second Faculty of Medicine, First Faculty of Medicine
- CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein2021 | Second Faculty of Medicine
- SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors2021 | Second Faculty of Medicine
Loading network view...